On the role of fronto-striatal neural synchronization processes for response inhibition-Evidence from ERP phase-synchronization analyses in pre-manifest Huntington's disease gene mutation carriers

Neuropsychologia

Volumn 49, Issue 12, 2011, Pages 3484-3493

  Beste, Christian ^a   Ness, Vanessa ^a   Falkenstein, Michael ^b   Saft, Carsten ^c  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Leibniz Research Centre Dortmund   (Germany)

^c ST JOSEF HOSPITAL   (Germany)

Author keywords

Compatibility effects; Event related potentials (ERPs); Huntington's disease; Neural synchronization; Response inhibition

Indexed keywords

FLUOXETINE; IMIPRAMINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL SYNCHRONIZATION; EVENT RELATED POTENTIAL; FEMALE; GENE MUTATION; HUMAN; HUNTINGTON CHOREA; MALE; NEUROPHYSIOLOGY; PREMOTOR CORTEX; RELIABILITY; SCORING SYSTEM; STIMULUS RESPONSE;

ADULT; ANALYSIS OF VARIANCE; BRAIN MAPPING; CONTINGENT NEGATIVE VARIATION; CORPUS STRIATUM; CORTICAL SYNCHRONIZATION; ELECTROENCEPHALOGRAPHY; FEMALE; FRONTAL LOBE; HUMANS; HUNTINGTON DISEASE; INHIBITION (PSYCHOLOGY); MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PHOTIC STIMULATION; REACTION TIME; TIME FACTORS;

EID: 80053583978     PISSN: 00283932     EISSN: 18733514     Source Type: Journal    
DOI: 10.1016/j.neuropsychologia.2011.08.024     Document Type: Article

References (47)

1. Antal A., Beniczky S., Kincses T.Z., Jakab K., Benedek G., Vecsei L. Perceptual categorization is impaired in Huntington's disease: An electrophysiological study. Dementia Geriatric Cognitive Disorders 2003, 16:187-192.
2. Aron A.R., Watkins L., Sahakian B.J., Monsell S., Barker R.A., Robbins T.W. Task-set switching deficits in early stage Huntington's disease: Implications for basal ganglia function. Journal of Cognitive Neuroscience 2003, 15:629-642.
3. Band G.P., van Boxtel G.J. Inhibitory motor control in stop paradigms: review and reinterpretation of neural mechanisms. Acta Psychologica (Amst.) 1999, 101:179-211.
4. Bar-Gad I., Morris G., Bergman H. Information processing, dimensionality reduction and reinforcement learning in the basal ganglia. Progress in Neurobiology 2003, 71:439-473.
5. Beste C., Baune B.T., Domschke K., Falkenstein M., Konrad C. Paradoxical association of the brain-derived-neurotrophic factor Val66Met genotype with response inhibition. Neuroscience 2010, 166:178-184.
6. Beste C., Baune B.T., Domschke K., Falkenstein M., Konrad C. Dissociable influences of NR2B-receptor related neural transmission on functions of distinct associative basal ganglia circuits. Neuroimage 2010, 52:309-315.
7. Beste C., Kolev V., Yordanova J., Domschke K., Falkenstein M., Baune B.T., et al. The role of BDNF Val66Met polymorphism for the synchronization of error-specific neural networks. Journal of Neuroscience 2010, 30:10727-10733.
8. Beste C., Willemssen R., Saft C., Falkenstein M. Response inhibition subprocesses and dopaminergic pathways: Basal ganglia disease effects. Neuropsychologia 2010, 48:366-373.
9. Beste C., Dziobek I., Hielscher H., Willemssen R., Falkenstein M. Effects of stimulus-response compatibility on inhibitory processes in Parkinson's disease. European Journal of Neuroscience 2009, 29:855-860.
10. Beste C., Willemssen R., Saft C., Falkenstein M. Error processing in normal aging and in basal ganglia disorders. Neuroscience 2009, 159:143-149.
11. Beste C., Saft C., Andrich J., Gold R., Falkenstein M. Response inhibition in Huntington's disease-A study using ERPs and sLORETA. Neuropsychologia 2008, 46:1290-1297.
12. Beste C., Saft C., Andrich J., Gold R., Falkenstein M. Stimulus-response compatibility in Huntington's disease: A cognitive-neurophysiological analysis. Journal of Neurophysiology 2008, 99:1213-1223.
13. Beste C., Saft C., Güntürkün O., Falkenstein M. Increased cognitive functioning in symptomatic Huntington's disease as revealed by behavioral and event-related potential indices of auditory sensory memory and attention. Journal of Neuroscience 2008, 28:11695-11702.
14. Beste C., Saft C., Yordanova J., Andrich J., Gold R., Falkenstein M., et al. Functional compensation or pathology in cortico-subcortical interaction in preclinical Huntington's disease. Neuropsychologia 2007, 45:2922-2930.
15. Bokura H., Yamaguchi S., Kobayashi S. Event-related potentials for response inhibition in Parkinson's disease. Neuropsychologia 2005, 43:967-975.
16. Cepeda C., Wu N., Andre V.M., Cummings D.M., Levine M.S. The corticostriatal pathway in Huntington's disease. Progress in Neurobiology 2007, 81:253-271.
17. DeLong M.R., Wichmann T. Circuits and circuit disorders of the basal ganglia. Archives of Neurology 2007, 64:20-24.
18. Falkenstein M., Hoormann J., Hohnsbein J. ERP components in Go/Nogo task and their relation to inhibition. Acta Psychologica 1999, 101:267-291.
19. Gurney K., Prescott T.J., Wickens J.R., Redgrave P. Computational models of the basal ganglia: From robots to membranes. Trends in Neuroscience 2004, 27:453-459.
20. Huntington's Disease Collaborative Research Group An novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72:971-983.
21. Huntington Study Group Unified Huntington's disease rating scale: Reliability and consistency. Movement Disorders 1996, 11:136-142.
22. Kitano K., Fukai T. Temporal characteristics of the predictive synchronous firing modeled by spike-timing dependent plasticity. Learning and Memory 2004, 11:267-276.
23. Kolev V., Yordanova J. Analysis of phase-locking is informative for studying event-related EEG activity. Biological Cybernetics 1997, 76:229-235.
24. Lago-Fernandez L.F., Corbacho F.J., Huerta R. Connection topology dependence of synchronization of neural assemblies on class I and II excitability. Neural Networks 2001, 14:687-696.
25. Langbehn D.R., Brinkman R.R., Falush D., Paulsen J.S., Hayden M.R. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clinical Genetics 2004, 65:267-277. International Huntington's disease collaborative group.
26. Mangun G.R. Neural mechanisms of visual selective attention. Psychophysiology 1995, 32:4-8.
27. Mitchell I.J., Cooper A.J., Griffith M.R. The selective vulnerability of striatopallidal neurons. Progress in Neurobiology 1999, 59:691-719.
28. Münte T.F., Ridao-Alonso M.E., Preinfalk J., Wieringa B.M., Matzke M., Dengler R., et al. An electrophysiological analysis of altered cognitive functions in Huntington's disease. Archives of Neurology 1997, 54:1089-1098.
29. Nguyen L., Bradshaw J.L., Stout J.C., Croft R.J., Georgiou-Karistianis N. Electrophysiological measures as potential biomarkers in Huntington's disease. Brain Research Reviews 2010, 64:177-194.
30. Nieuwenhuis S., Yeung N., van den Wildenberg W., Ridderinkhof K.R. Electrophysiological correlates of anterior cingulate function in a go/nogo task: Effects of response conflict and trial type frequency. Cognitive Affective and Behavioural Neuroscience 2003, 3:17-26.
31. Nunez P.L., Srinivasan R., Westdorp A.F., Wjiesinghe R.S., Tucker D.M., Silberstein R.B., et al. EEG coherency. I: Statistics, reference electrode, volume conduction, Laplacians, cortical imaging, and interpretation at multiple scales. Electroencephalography Clinical Neurophysiology 1997, 103:499-515.
32. Ocklenburg S., Güntürkün O., Beste C. Lateralized neural mechanisms underlying the modulation of response inhibition processes. Neuroimage 2011, 55:1771-1778.
33. Penney J.B., Vonsattel J.P., MacDonald M.E., Gusella J.F., Myers R.H. CAG repeat number governs the development rate of pathology in Huntington's disease. Annals of Neurology 1997, 41:689-692.
34. Perrin F., Pernier J., Bertrand O., Echalier J.F. Spherical splines for scalp potential and current density mapping. Electroencephaolgraphy Clinical Neurophysiology 1989, 72:184-187.
35. Pivik R.T., Broughton R.J., Coppola R., Davidson R.J., Fox N., Nuwer M.R. Guidelines for the recording and quantitative analysis of electroencephalographic activity in research contexts. Psychophysiology 1993, 30:547-558.
36. Praamstra P., Plat F.M. Failed suppression of direct visuomotor activation in Parkinson's disease. Journal of Cognitive Neuroscience 2001, 13:547-558.
37. Redgrave P., Gurney K. The short-latency dopamine signal: A role in discovering novel actions?. Nature Reviews Neuroscience 2006, 7:967-975.
38. Redgrave P., Prescott T.J., Gurney K. The basal ganglia: A vertebrate solution to the selection problem?. Neuroscience 1999, 89:1009-1023.
39. Redgrave P., Rodriguez M., Smith Y., Rodriguez-Oroz M.C., Lehericy S., Bergman H., et al. Goal-directed and habitual control in the basal ganglia: Implications for Parkinson's disease. Nature Reviews Neuroscience 2010, 11:760-772.
40. Roach B.J., Mathalon D.H. Event-related EEG time-frequency analysis: An overview of measures and an analysis of early gamma band phase locking in schizophrenia. Schizophrenia Bulletin 2008, 34:907-926.
41. Roche R.A., Garavan H., Foxe J.J., O'Mara S.M. Individual differences discriminate event-related potentials but not performance during response inhibition. Experimental Brain Research 2005, 160:60-70.
42. Rosas H.D., Salat D.H., Lee S.Y., Zaleta A.K., Pappu V., Fischl B., et al. Cerebral cortex and the clinical expression of Huntington's disease: Complexity and heterogeneity. Brain 2008, 131:1057-1068.
43. Stout J.C., Paulsen J.S., Queller S., Solomon A.C., Whitlock K.B., Campbell J.C., et al. Neurocognitive signs in prodomal Huntington disease. Neuropsychology 2011, 25:1-14.
44. Tabrizi S.J., Langbehn D.R., Leavitt B.R., Roos R.A., Durr A., Craufurd D., et al. Biological and clinical manifestation of Huntington's disease in the longitudinal TRACK-HD study: Cross-sectional analysis of baseline data. Lancet Neurology 2009, 8:791-801.
45. Tallon-Baudry C., Bertrand O., Fischer C. Oscillatory synchrony between human extrastraite areas during visual short-term memory maintenance. Journal of Neuroscience 2001, 21:RC177.
46. Thomas E.A., Coppola G., Tang B., Kuhn A., Kim S., Geschwind D.H., et al. In vivo cell-autonomous transcriptional abnormalities revealed in mice expressing mutant huntingtin in striatal but not cortical neurons. Human Molecular Genetics 2011, 20:1049-1060.
47. van der Hiele K., Jürgens C.K., Vein A.A., Reijntjes R.H., Witjes-Ane M.N., Roos R.A., et al. Memory activation reveals abnormal EEG in preclinical Huntington's disease. Movement Disorders 2007, 22:690-695.